Enteral Access Technologies Ltd.
Enteral Access Technologies Ltd. (EAT) is a Liverpool-based MedTech company founded in 2018. They develop medical devices that improve the safety and efficiency of nasogastric and orogastric tube placement. Their main product, DoubleCHEK™, combines CO₂ and pH measurements to reduce misplacement risks and enable faster, more accurate tube placement without special equipment.
Finanzierungsrunden
1
Gesamtvolumen
€605K
Letzte Runde
Bridge
Investoren
1
Finanzierung nach Stage
Investoren (1)
Finanzierungsrunden
| Stage | Betrag | Investoren | Datum |
|---|---|---|---|
| Bridge | €605K | 11. Nov. 2025 |
